News Archive

A survey of 2,638 Duke Health patients who had total replacement of knee, hip, or shoulder joints in 2014-20 found that approximately one-third experienced high-impact or bothersome chronic pain fo

With $21 million in new funding from the NIAID, the network now includes eight centers in North America and will study adolescent lung transplant recipients as well as adult.

Stakeholders at a January 2020 DCRI Think Tank examined the role of machine learning (ML) in the design, conduct, and analysis of clinical trials.

Until now, scientific research about treatment for the most common type of heart arrythmia, atrial fibrillation (AFib), has primarily focused on patients with already established cases of the condition. CHANGE AFib, a new pragmatic clinical trial, will determine whether early treatment with the antiarrhythmic drug dronedarone improves cardiovascular and long-term outcomes in patients presenting to the hospital with first-detected AFib.

A new project led by the Cardiac Safety Research Consortium created a first-in-kind data warehouse to help ensure comprehensive cardiac safety review for therapeutic product development for children.

The ABC Science Collaborative’s latest study published in Pediatrics includes data from 20 school districts during summer 2021, when the Delta variant became the dominant strain of SARS-CoV-2 in th

The below is a republication of a story that featured DCRI’s Charlene Wong, MD, MSHP, which appeared in Duke University School of Medicine’s digital publication, Magnify.

DCRI principal investigators lead the clinical and data coordinating centers for a new study that will evaluate a model of care that centers on non-pharmacological treatment options.

A new consortium called the CardioHealth Alliance will bring together a multi-disciplinary group of experts to improve the care and health of patients across cardiovascular, renal, and metabolic diseases. The alliance, which was established by leaders from the Duke Clinical Research Institute (DCRI) and the Stanford Center for Clinical Research (SCCR), welcomes Novartis Pharmaceuticals Corporation (“Novartis”) as a founding member and initial funding partner and invites clinicians, patients, data scientists, health care leaders, and policy makers to partner to improve disease care pathways and expedite the implementation of evidence into practice.

An ancillary study found improvements in a composite heart failure quality score after patients used a mobile app to help them manage their heart failure.